Category In The News

June 13, 2014 12:12 PM
Your Body's Secret Weapon (Itself)

Progress continues on the UF pediatric immunotherapy trial funded by ABC2, FBTA and Paul Hale of the Bret Hale Memorial Fund.

June 10, 2014 12:26 PM
Newly Identified Brain Cancer Mutation Will Aid Drug Development

ABC2 funded the research of Hai Yan, M.D., Ph.D., at Duke University School of Medicine.

June 4, 2014 10:31 AM
Parasite Treatment May Help People With Brain Cancer

This ABC2-funded research by Dr. Greg Riggins at Johns Hopkins University is featured in The Baltimore Sun.

May 29, 2014 09:07 PM
Seeking Alpha: "Celldex: The Race Leader in Glioblastoma Multiforme"

We've funded early research at Duke that's now being developed by Celldex - a leading company featured in the Seeking Alpha article.

May 8, 2014 03:58 PM
Thank You To Our Race For Hope Community

A message from Max Wallace, CEO of Accelerate Brain Cancer Cure.

April 9, 2014 03:21 PM
5th Annual Florida Brain Cancer 5k - A Record-Breaking Success!

More than 1400 participants, 73 teams and dozens of sponsors raised $209,000 for brain cancer research in the state of Florida.

February 27, 2014 04:35 PM
Pediatric Cancer Advocates Meet With National Cancer Institute Leadership To Advance Research

ABC2's Max Wallace leads the NCI's Director's Consumer Liaison Group that addresses research issues critical to improving outcomes for patients with all types of cancers.

February 26, 2014 12:00 AM
Neuro-Oncology Field Sets Action Plan to Advance Use of Imaging-Related Endpoints In Clinical Trials

The coalition includes Accelerate Brain Cancer Cure, the Musella Foundation for Brain Tumor Research and Information, the National Brain Tumor Society and the Society for Neuro-Oncology.

February 20, 2014 03:29 PM
Benefit of Bevacizumab in Glioblastoma Under Discussion

An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM.  ABC2's petitioning of the FDA is noted.

January 31, 2014 05:22 PM
When Will Genomics Cure Cancer?

An interview with biogeneticist Eric S. Lander in the January/February issue of The Atlantic.

Pages

Share |

Join us in our fight for a cure!